Previous 10 | Next 10 |
The following slide deck was published by Amarin Corporation plc in conjunction with this event. For further details see: Amarin JPM Presentation 2023
Amarin Corporation plc (AMRN) 41st Annual J.P. Morgan Healthcare Conference January 10, 2023 8:15 p.m. ET Company Participants Karim Mikhail - President and Chief Executive Officer Tom Reilly - Chief Financial Officer Presentation [Call Starts Abruptly] -- in E...
Sarissa Capital Management, Amarin Corp.'s ( NASDAQ: AMRN ) largest shareholder, is calling for a special meeting of shareholders to remove the current board chairman and add its backed representatives. Amarin ( AMRN ) is up ~19% in Tuesday afternoon terading. Sarissa said...
Sarissa believes current board lacks any remaining credibility for representing shareholders Sarissa is astonished that Amarin board refuses to add shareholder representatives Sarissa Capital Management LP (“Sarissa”) today made the following statement on Amarin Co...
Amarin Corporation ( NASDAQ: AMRN ), the maker of fish oil-derived therapy Vascepa/Vazkepa, preannounced its Q4 and 2022 financials on Tuesday, reporting the fourth consecutive quarter of U.S. revenue stabilization despite additional generic competition. Citing early unaudited financi...
-- Company Delivers Fourth Consecutive Quarter of U.S. Revenue Stabilization, Positive Fourth Quarter Cash Flow and Continued Progress on European Reimbursements -- -- Amarin to Present at 41st Annual J.P. Morgan Healthcare Conference on January 10, 2023 -- DUBLIN, Ireland and BRIDG...
-- Dr. Stewart Brings More Than 30 Years of Cardiometabolic Academic and Industry Experience to Amarin’s Board –- - - Ongoing Board Refreshment Program Has Led to Approximately 70% New Independent Directors Named to the Board Over the Last 12 Months -- DUBLIN, Ir...
Penny Stocks To Watch This Month The latest round of jobs data is out, and the stock market climbed as a result. But shortly after the opening bell, broad indexes pulled in. That wasn’t the case for all stocks, however. If you’re familiar with penny stocks , you know this ty...
Summary Amarin continues to lose market share in the U.S. as it faces stiff competition from generic drug-makers. In Europe, AMRN may struggle to achieve the goal of getting reimbursement and launching in multiple countries without compromising on price. AMRN may face more than expe...
DUBLIN, Ireland and BRIDGEWATER, N.J., Dec. 14, 2022 (GLOBE NEWSWIRE) -- Amarin Corporation plc (NASDAQ:AMRN) today announced that Karim Mikhail, Amarin’s president and chief executive officer, is scheduled to participate at the 41st Annual J.P. Morgan Healthcare Conference on January 10, ...
News, Short Squeeze, Breakout and More Instantly...
Amarin Corporation plc Company Name:
AMRN Stock Symbol:
NASDAQ Market:
Amarin Corporation plc Website:
2024-07-31 14:15:16 ET Image source: The Motley Fool. Amarin Plc (NASDAQ: AMRN) Q2 2024 Earnings Call Jul 31, 2024 , 8:00 a.m. ET Operator Continue reading For further details see: Amarin Plc (AMRN) Q2 2024 Earnings Call Transcript
Dayforce Inc. (DAY) is expected to report $0.18 for Q2 2024 D/B/A Compass Diversified Holdings Shares of Beneficial Interest (CODI) is expected to report $0.44 for Q2 2024 Aurora Innovation Inc. (AUR) is expected to report for Q2 2024 Autohome Inc. American Depositary Shares each repr...
-- Portuguese Ministry of Health approves VAZKEPA® (icosapent ethyl) for national reimbursement to reduce the risk of cardiovascular (CV) events in patients with established cardiovascular disease (CVD) 1 -- -- Approval marks eighth national reimbursement of VAZKEPA®...